Innate Killer Summit 2017

This event is dedicated to helping researchers take critical steps to enhance biological understanding, ensure successful translation and effective clinical development of natural killer, NKT & γδ T cell immunotherapies.

Researchers will access exclusive, cutting-edge data and the latest clinical progress needed to implement a best practice approach to progress the cell pipeline with a forward-looking plan for global manufacture and distribution to patients in need. Attendees will also be able to capitalize on more robust allogeneic development approaches and overcome safety concerns experienced by other cell therapies.